Skip to main navigation

Home
Pipeline
Interleukin-1⍺ Infectious Diseases SARS-COV-2 / COVID 19 Clinical
Technology
True Human™ Antibodies Manufacturing
About
About XBiotech Leadership Careers Contact
Investors

Investors

Investors
Overview
Stock Information
Press Releases
Corporate Governance
Financial Information
Investor FAQ
Contact Investor Relations

Shareholder Tools

Print Page
Email Alerts
RSS Feeds

Press Releases

Press Releases

Keyword Search

Year

04 Jan '2024

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

XBIOTECH USA, INC.

5217 Winnebago Ln.

Austin, TX 78744

CALL: (512) 386- 2900

FAX: (512) 386-5505

publicrelations@xbiotech.com

Privacy Policy